Views on the news: politics, not logic, will drive EU medtech reg outcome
10 May 2013
- INTERVIEW: Current ‘Wait-And-See’ State Of EU Regs Not Good for Industry
- AUDITORS’ ORATORY: what challenges do drug/device combinations bring to notified bodies and manufacturers?
- EU vs US: Which Medtech Launch Market Offers Best Returns?
- EU Medtech Reform Proposals May Jeopardize Authorized Reps And Exacerbate 'Ghost' Problem
Other Informa News